Gail S. Duncan

451 total citations
13 papers, 374 citations indexed

About

Gail S. Duncan is a scholar working on Physiology, Epidemiology and Immunology. According to data from OpenAlex, Gail S. Duncan has authored 13 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Gail S. Duncan's work include Adenosine and Purinergic Signaling (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and Macrophage Migration Inhibitory Factor (5 papers). Gail S. Duncan is often cited by papers focused on Adenosine and Purinergic Signaling (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and Macrophage Migration Inhibitory Factor (5 papers). Gail S. Duncan collaborates with scholars based in United States. Gail S. Duncan's co-authors include Thomas P. Zimmerman, Gerald Wolberg, Gertrude B. Elion, Claus J. Schmitges, Janet L. Rideout, Kay H. Singer, Wayne H. Miller, Richard L. Miller, Mu‐Ill Lim and Robert S. Klein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Gail S. Duncan

13 papers receiving 317 citations

Peers

Countries citing papers authored by Gail S. Duncan

Since Specialization

Citations

This map shows the geographic impact of Gail S. Duncan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail S. Duncan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail S. Duncan more than expected).

Fields of papers citing papers by Gail S. Duncan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail S. Duncan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail S. Duncan. The network helps show where Gail S. Duncan may publish in the future.

Co-authorship network of co-authors of Gail S. Duncan

This figure shows the co-authorship network connecting the top 25 collaborators of Gail S. Duncan. A scholar is included among the top collaborators of Gail S. Duncan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail S. Duncan. Gail S. Duncan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Inhibition of lymphocyte function by 9-deazaadenosine 1983 ·Biochemical Pharmacology ·Thomas P. Zimmerman, (unknown), Gerald Wolberg, (unknown), Gail S. Duncan, Wayne H. Miller, Richard L. Miller, Mu‐Ill Lim, (unknown), Robert S. Klein	34
2	Inhibition of Lymphocyte-Mediated Cytolysis and Cyclic amp Phosphodiesterase byErythro-9–(2-Hydroxy-3-Nonyl)Adenine 1982 ·PubMed ·Gail S. Duncan, Gerald Wolberg, Claus J. Schmitges, (unknown), Thomas P. Zimmerman	7
3	Inhibition of lymphocyte cyclic AMP phosphodiesterase and lymphocyte function by 5′-methylthioadenosine 1982 ·Biochemical Pharmacology ·Gerald Wolberg, Thomas P. Zimmerman, Claus J. Schmitges, Gail S. Duncan, (unknown)	15
4	Inhibition of cyclic amp phosphodiesterase by 5'-deoxy-5'-S-isobutylthioadenosine at biologically active concentrations of drug 1981 ·Life Sciences ·Thomas P. Zimmerman, Claus J. Schmitges, Gerald Wolberg, (unknown), Gail S. Duncan	12
5	Modulation of cyclic AMP metabolism by S-adenosylhomocysteine and S-3-deazaadenosylhomocysteine in mouse lymphocytes. 1980 ·Proceedings of the National Academy of Sciences ·Thomas P. Zimmerman, Claus J. Schmitges, Gerald Wolberg, (unknown), Gail S. Duncan, (unknown), Gertrude B. Elion	52
6	Adenosine analogs as substrates and inhibitors of S-adenosylhomocysteine hydrolase in intact lymphocytes 1980 ·Biochemistry ·Thomas P. Zimmerman, Gerald Wolberg, Gail S. Duncan, Gertrude B. Elion	40
7	Potentiation by homocysteine of adenosine-stimulated elevation of cellular adenosine 3′,5′-monophosphate 1979 ·Biochemical Pharmacology ·Thomas P. Zimmerman, (unknown), Gerald Wolberg, Gail S. Duncan	12
8	Metabolic formation of nucleoside-modified analogues of S-adenosylmethionine 1979 ·Biochemical and Biophysical Research Communications ·Thomas P. Zimmerman, (unknown), Gerald Wolberg, Gail S. Duncan	19
9	Inhibition of lymphocyte-mediated cytolysis by adenosine analogs 1978 ·Biochemical Pharmacology ·Gerald Wolberg, Thomas P. Zimmerman, Gail S. Duncan, Kay H. Singer, Gertrude B. Elion	37
10	Inhibition of lymphocyte-mediated cytolysis by 2-fluoroadenosine- 1978 ·Biochemical Pharmacology ·Thomas P. Zimmerman, Gerald Wolberg, Gail S. Duncan, Janet L. Rideout, L M Beacham, Thomas A. Krenitsky, Gertrude B. Elion	8
11	Inhibition of lymphocyte-mediated cytolysis by 3-deazaadenosine: Evidence for a methylation reaction essential to cytolysis 1978 ·Proceedings of the National Academy of Sciences ·Thomas P. Zimmerman, Gerald Wolberg, Gail S. Duncan	83
12	Metabolism of tubercidin and formycin to their 3‘:5‘-cyclic nucleotides in mammalian cells. 1978 ·Journal of Biological Chemistry ·Thomas P. Zimmerman, Gerald Wolberg, Gail S. Duncan	10
13	2-Fluoroadenosine 3':5'-monophosphate. A metabolite of 2-fluoroadenosine in mouse cytotoxic lymphocytes. 1976 ·Journal of Biological Chemistry ·Thomas P. Zimmerman, Janet L. Rideout, Gerald Wolberg, Gail S. Duncan, Gertrude B. Elion	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact